febuxostat has been researched along with luteolin in 4 studies
Studies (febuxostat) | Trials (febuxostat) | Recent Studies (post-2010) (febuxostat) | Studies (luteolin) | Trials (luteolin) | Recent Studies (post-2010) (luteolin) |
---|---|---|---|---|---|
818 | 133 | 710 | 2,402 | 15 | 1,648 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderluh, M; Jakopin, Ž; Kocić, G; Petronijević, Ž; Šmelcerović, A; Šmelcerović, Ž; Tomašič, T; Tomović, K | 1 |
Fu, P; Li, X; Liu, J; Ma, L | 1 |
Chen, J; Fu, Y; Li, P; Mo, HY; Song, HP; Zhang, H; Zhang, M | 1 |
Baunthiyal, M; Gupta, A; Pathak, RK; Shukla, R | 1 |
2 review(s) available for febuxostat and luteolin
Article | Year |
---|---|
Xanthine oxidase inhibitors beyond allopurinol and febuxostat; an overview and selection of potential leads based on in silico calculated physico-chemical properties, predicted pharmacokinetics and toxicity.
Topics: Allopurinol; Computer Simulation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Febuxostat; Humans; Molecular Structure; Structure-Activity Relationship; Xanthine Oxidase | 2017 |
Pharmacological urate-lowering approaches in chronic kidney disease.
Topics: Biological Products; Drug Discovery; Flavonoids; Humans; Renal Insufficiency, Chronic; Uric Acid | 2019 |
2 other study(ies) available for febuxostat and luteolin
Article | Year |
---|---|
Screening for selective inhibitors of xanthine oxidase from Flos Chrysanthemum using ultrafiltration LC-MS combined with enzyme channel blocking.
Topics: Apigenin; Catalytic Domain; Chromatography, Liquid; Chrysanthemum; Drugs, Chinese Herbal; Enzyme Inhibitors; Febuxostat; Flavones; Flowers; Glucosides; Gout Suppressants; Luteolin; Mass Spectrometry; Thiazoles; Ultrafiltration; Xanthine Oxidase | 2014 |
Identification of new drug-like compounds from millets as Xanthine oxidoreductase inhibitors for treatment of Hyperuricemia: A molecular docking and simulation study.
Topics: Allopurinol; Enzyme Inhibitors; Febuxostat; Humans; Hydrogen Bonding; Hyperuricemia; Ligands; Luteolin; Millets; Molecular Docking Simulation; Molecular Dynamics Simulation; Principal Component Analysis; Quercetin; Xanthine Dehydrogenase | 2018 |